I now have comprehensive information to provide a detailed prescribing guide. Let me compile the answer.
Prescribing Gabapentin + Nortriptyline Combination for Neuropathic Pain
Why Combine Them?
Gabapentin (calcium channel α2δ ligand) and nortriptyline (TCA — norepinephrine/serotonin reuptake inhibitor) work via entirely different mechanisms. They act additively at the CNS level, and the combination has Level I RCT evidence (Gilron et al., 2009 — Lancet) showing superiority over either drug alone for diabetic neuropathic pain and postherpetic neuralgia. Goldman-Cecil notes they "provide superior benefit than either drug alone for neuropathic pain." The combination is a recognized second-line strategy in neuropathic pain guidelines (NICE CG173) when monotherapy is partially effective.
Indications
- Diabetic peripheral neuropathy
- Postherpetic neuralgia (PHN)
- Other peripheral neuropathic pain partially responsive to one agent alone
Prescribing Protocol
Step 1 — Start One Agent First (Monotherapy → Combination)
Most practical approach: Start gabapentin alone, titrate to effect. If pain is still poorly controlled at maximum tolerated dose, add nortriptyline at a low dose. Alternatively, you may initiate both together at low doses.
Gabapentin — Dosing & Titration
| Phase | Dose | Schedule |
|---|
| Day 1–2 | 300 mg | Once at night |
| Day 3–4 | 300 mg | Twice daily |
| Day 5–7 | 600 mg | Twice daily |
| Week 2+ | 600 mg | Three times daily (1800 mg/d) |
| Target effective range | 1200–3600 mg/day | Divided TID |
| Maximum | 3600 mg/day | — |
- Start at 100 mg (not 300 mg) in the elderly, frail, or those with renal impairment
- Increase by 100–300 mg every 1–3 days as tolerated
- Renal dose reduction required: GFR 30–59 → max 700 mg TID; GFR 15–29 → max 700 mg BID; GFR <15 → max 300 mg once daily
- Asymmetric dosing (larger evening dose) helps if daytime sedation/cognitive effects limit titration
(Harrison's 22e; Palliative Care Network of Wisconsin, 2024)
Nortriptyline — Dosing & Titration
| Phase | Dose | Notes |
|---|
| Start | 10 mg at bedtime (elderly/frail) or 25 mg at bedtime | Lower starting dose than for depression |
| Titrate | Increase by 10–25 mg every 1–2 weeks | |
| Analgesic range | 25–75 mg/day (often at bedtime) | Lower than antidepressant doses |
| Maximum (pain) | 75–150 mg/day | |
| Dosing time | Once daily at night | Long half-life; bedtime dosing improves sleep, reduces daytime sedation |
- Nortriptyline is preferred over amitriptyline for neuropathic pain because it has fewer anticholinergic and sedative side effects
- Analgesic effect is independent of antidepressant effect — works even in non-depressed patients
- Pre-prescribing ECG is recommended in patients >40 years old or with cardiac history (QTc prolongation risk)
(Cummings Otolaryngology; Goldman-Cecil Medicine)
Combination Dosing in Practice
When combining, use lower doses of each agent than you would with monotherapy to minimize additive side effects:
| Drug | Typical combination dose |
|---|
| Gabapentin | 900–1800 mg/day (TID) |
| Nortriptyline | 10–50 mg at bedtime |
Titrate each independently. Aim for adequate analgesia (≥30% pain reduction) with acceptable tolerability.
Monitoring
| Parameter | Action |
|---|
| Pain score (0–10) | Reassess at 3–4 weeks of each dose adjustment |
| ECG | Before starting nortriptyline, especially in elderly or cardiac patients |
| Renal function | Adjust gabapentin if GFR changes |
| Sedation/cognitive function | Especially in elderly — use lower doses |
| QTc | Monitor if adding other QT-prolonging drugs |
| Constipation/urinary retention | Nortriptyline anticholinergic effects |
Contraindications / Cautions
Nortriptyline contraindications:
- Recent MI or unstable cardiac arrhythmia
- Closed-angle glaucoma
- Concurrent MAOIs (serotonin syndrome risk)
- Prostatic hypertrophy / urinary retention
- Caution with other serotonergic agents (low risk of serotonin syndrome vs. tramadol — monitor)
Gabapentin cautions:
- Renal impairment (dose-reduce)
- Elderly (confusion, falls, sedation — start low)
- Avoid abrupt discontinuation (taper over ≥1 week to prevent withdrawal seizures)
- Controlled substance in many jurisdictions — monitor for misuse
Stopping / Tapering
| Drug | Taper schedule |
|---|
| Nortriptyline | Reduce by 10 mg/week |
| Gabapentin >900 mg/day | Reduce by 300 mg every 4 days |
| Gabapentin ≤900 mg/day | Reduce by 100 mg every 4 days |
Key Evidence
The Gilron et al. (2009) double-blind, randomised crossover trial (Lancet 374:1252–1261) remains the landmark study, directly comparing nortriptyline alone, gabapentin alone, and the combination for diabetic neuropathy and PHN. The combination produced significantly lower pain scores than either monotherapy with manageable side effects. The number needed to treat for neuropathic pain drugs ranges from 3–7, so expect 3–4 week trials before judging efficacy.
Recent evidence note: A 2024 JAMA review on peripheral neuropathy (PMID 41247746) and a 2024 review on neuropathic pain pharmacology (PMID 39385859) confirm the combination remains current practice — no evidence contradicting this approach has emerged.
Summary: Start-Low, Go-Slow Protocol
- Gabapentin 100–300 mg at night → titrate to 1200–1800 mg/day TID over 2–3 weeks
- If partial response: add nortriptyline 10–25 mg at bedtime → titrate by 10–25 mg every 1–2 weeks to 25–75 mg/day
- Review at 3–4 weeks of stable dosing — if no ≥30% pain reduction at max tolerated dose, consider switching or escalating to 3rd-line treatment
- Baseline ECG before nortriptyline; renal function for gabapentin dosing